GB0207447D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0207447D0
GB0207447D0 GBGB0207447.4A GB0207447A GB0207447D0 GB 0207447 D0 GB0207447 D0 GB 0207447D0 GB 0207447 A GB0207447 A GB 0207447A GB 0207447 D0 GB0207447 D0 GB 0207447D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0207447.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0207447.4A priority Critical patent/GB0207447D0/en
Publication of GB0207447D0 publication Critical patent/GB0207447D0/en
Priority to TW092106774A priority patent/TW200401771A/en
Priority to AU2003226758A priority patent/AU2003226758A1/en
Priority to JP2003580302A priority patent/JP2006504626A/en
Priority to PCT/EP2003/003338 priority patent/WO2003082834A2/en
Priority to EP03745295A priority patent/EP1490345A2/en
Priority to ARP030101089A priority patent/AR039176A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0207447.4A 2002-03-28 2002-03-28 Novel compounds Ceased GB0207447D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0207447.4A GB0207447D0 (en) 2002-03-28 2002-03-28 Novel compounds
TW092106774A TW200401771A (en) 2002-03-28 2003-03-26 Novel compound
AU2003226758A AU2003226758A1 (en) 2002-03-28 2003-03-27 Morpholine derivatives and intermediates therefor
JP2003580302A JP2006504626A (en) 2002-03-28 2003-03-27 Morpholine derivatives and intermediates thereof
PCT/EP2003/003338 WO2003082834A2 (en) 2002-03-28 2003-03-27 Morpholine derivatives and intermediates therefor
EP03745295A EP1490345A2 (en) 2002-03-28 2003-03-27 Novel compound
ARP030101089A AR039176A1 (en) 2002-03-28 2003-03-27 NEW COMPOUND

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207447.4A GB0207447D0 (en) 2002-03-28 2002-03-28 Novel compounds

Publications (1)

Publication Number Publication Date
GB0207447D0 true GB0207447D0 (en) 2002-05-08

Family

ID=9933997

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0207447.4A Ceased GB0207447D0 (en) 2002-03-28 2002-03-28 Novel compounds

Country Status (7)

Country Link
EP (1) EP1490345A2 (en)
JP (1) JP2006504626A (en)
AR (1) AR039176A1 (en)
AU (1) AU2003226758A1 (en)
GB (1) GB0207447D0 (en)
TW (1) TW200401771A (en)
WO (1) WO2003082834A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870074A (en) * 1986-04-30 1989-09-26 Dainippon Pharmaceutical Co., Ltd. Substituted benzamide derivatives, for enhancing gastrointestinal motility
KR970703301A (en) * 1994-05-18 1997-07-03 쇼오다 오사무 Novel Diaminomethylidene Derivatives (NOVEL DIAMINCMETHYLIDENE DERIVATIVE)
KR970703324A (en) * 1994-05-18 1997-07-03 쇼오다 오사무 Novel pyrimidine derivatives (NOVEL PYRIMIDINE DERIVATIVE)
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
NZ525055A (en) * 2000-09-29 2004-09-24 Glaxo Group Ltd Compounds useful in the treatment of inflammatory diseases

Also Published As

Publication number Publication date
JP2006504626A (en) 2006-02-09
TW200401771A (en) 2004-02-01
AU2003226758A1 (en) 2003-10-13
AU2003226758A8 (en) 2003-10-13
WO2003082834A2 (en) 2003-10-09
WO2003082834A3 (en) 2004-03-25
AR039176A1 (en) 2005-02-09
EP1490345A2 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0207432D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds
GB0201357D0 (en) Novel compounds
GB0207275D0 (en) Novel compounds
GB0207282D0 (en) Novel compounds
GB0203301D0 (en) Novel compounds
GB0203300D0 (en) Novel compounds
GB0203437D0 (en) Novel compounds
GB0207281D0 (en) Novel compounds
GB0203673D0 (en) Novel compounds
GB0202637D0 (en) Novel compounds
GB0207278D0 (en) Novel compounds
GB0203677D0 (en) Novel compounds
GB0202636D0 (en) Novel compounds
GB0202442D0 (en) Novel compounds
GB0202219D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)